RCEL: AVITA Medical Inc. Consensus Target

AVITA Medical, Inc. (RCEL) operates within an autonomous product cycle, where stable interest in medical innovations renders the asset a reliable defensive asset. The business implements ReCell systems for the automated creation of cell suspensions, streamlining the workflow for physicians treating burns. This price chart, featuring the 17.77 indicator, links these achievements to the sector's resilience, as skin injury care remains crisis-independent and success relies on the expansion of insurance reimbursements.

RCEL avitamedical.com Price Target Chart (07/04/2022 - 11/12/2026)

Analytical breakdowns for AVITA Medical, Inc (RCEL)

- share price and consensus valuation forecast:

Price Performance Chart avitamedical.com|RCEL - Analyst Consensus Forecast

- market capitalization information:

Market Valuation AVITA Medical, Inc|RCEL - Enterprise Value

- book value of equity indicators:

Net Asset Value per Share AVITA Medical|RCEL - Company Book Value|Market Value to Book Value Ratio avitamedical.com|RCEL - Cumulative Company Assets

- debt obligations and liquidity statistics:

- earnings and multiples data:

RCEL - Company Net Income|Forward Earnings AVITA Medical, Inc.|RCEL - P/E Multiple|Projected Price to Earnings Ratio AVITA Medical Inc.|RCEL - Price/Earnings to Growth Multiple|EV/EBITDA Multiple AVITA Medical, Inc|RCEL - Operating profit before deduction of amortization|Earnings per share for the last four quarters AVITA Medical|RCEL - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months avitamedical.com|RCEL - Earnings growth in current year|Expected earnings per share growth for next year AVITA Medical, Inc.

General company analysis:RCEL - avitamedical.com

This indicator aggregates the average expectations of professional analysts regarding the asset's fair value, identifying fundamental business revaluation trends. The current consensus target price action on GURU.Markets reflects market confidence in RECELL technologies, where stable forecasts confirm the exceptional authority of AVITA Medical, Inc. (RCEL) within the regenerative medicine segment and its high standards for treating burn injuries.

Competitors of AVITA Medical, Inc.